CARBYLAN THERAPEUTICS INC / KALVISTA PHARMACEUTICALS LTD / Reverse Takeover / Public / £105m

Synopsis

Reverse merger of Carbylan Therapeutics, a developer of clinical-stage specialty pharmaceutical treatments, with KalVista Pharmaceuticals.

Principals

Carbylan Therapeutics

Kalvista Pharmaceuticals

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

latham & watkins

HQ - New York, United States

legal advisors

target

5445

Deals

£ 3,505.44 B

Total Value